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Summary.-Bleomycin inhibits cell division in HeLa S-3 and other mammalian
epithelial cell lines. Its effect on suspension cultured cells is far greater than on
monolayer cells; this was found to be due partly to the absence of divalent ions.
Other mammalian epithelial lines in suspension culture are very sensitive but
fibroblastic cells (BHK21/C13/DWS-3) grown under identical conditions are relatively
insensitive. This study has established that bleomycin is a powerful anti-mitotic
agent during the G2 phase but it does not prevent prophase cells from completing a
normal mitotic division. Its ability to suppress DNA synthesis contributes little
to the inhibition of cell cycling.
BLEOMYCIN and phleomycin are anti-
biotics obtained from Streptomyces verti-
cillus which were isolated by Umezawa's
group (Tanaka, Yamaguchi and Umezawa,
1963a; Umezawa et al., 1966, 1968b;
Ishizuka et al., 1967). They are poly-
peptide in nature and contain unusual
amino acids and copper. IBleomycin has
been fractionated and full activity is
retained by various fractions both with
and without the copper-containing moiety
(Suzuki et al., 1968). Although current
interest in bleomycin has been stimulated
by encouraging results in the chemo-
therapy of epithelial tumours (Ichikawa
et al., 1967; Clinical Screening Co-opera-
tive Group, E.O.R.T.C., 1970; Shastri et
al., 1971), its unique anti-mitotic proper-
ties make it very valuable for analyzing
premitotic stages ofthe cell cycle.
Bleomycin and phleomycin have rela-
tively little effect on protein synthesis in
mammalian cells and bacteria, but they
do inhibit DNA synthesis to some extent
(Tanaka, Yamaguchi and Umezawa,
1963b; Kunimoto, Hori and Umezawa,
1967; Suzuki et al., 1969), an effect which
can appear more pronounced in bacteria
(Pietsch and Clapper, 1969). The anti-
biotics interact with DNA both in vitro
and in vivo, Pietsch and his colleagues
(Pietsch and Garrett, 1968; Pietsch,
1969) suggesting linkage of phleomycin
to the oxygen in the C2 position of
thymidine.
Interaction of the antibiotics with
DNA and suppression of DNA synthesis
can prevent the progression of cells from
S phase to G2 in the cell cycle. Recent
studies (Kajiwara and Mueller, unpub-
lished, see Mueller, 1971) have demon-
strated the necessity for complete replica-
tion of the genome before cells can
progress from S phase to G2 and into
mitosis, inhibition of the last 3-4% of
DNA synthesis (" late-late replicating "
DNA) blocking the progression of cells
into mitosis. Deficits of this order could
have been overlooked as experimental
error before (Kajiwara, Kim and Mueller,
1966) and it remains to be established
whether bleomycin (and phleomycin) can
act after replication of the genome is
100% complete. The effects of bleo-
mycin (and phleomycin) on mammalian
cell cultuires were re-examined to analyseD. N. WHEATLEY, G. C. MUELLER AND K. KAJIWARA
more precisely its time of action and
mechanism of interference in the cell
cycle.
MATERIALS AND METHODS
Chemicals.-Bleomycin A2 was obtained
from Dr Umezawa (Lot Numbers 33 and
F-1921, NipponKayaku Co., Tokyo). Phleo-
mycin wasobtainedfromBristolLaboratories,
Syracuse, N.Y., U.S.A. (Lot Number 64L68).
Hydroxyurea (Nutritional Biochemicals
Corp. and British Drug Houses) was pre-
pared at 2 x 10-1 mol/l and colcemid
(Demecolcin, CIBA) at 1 5 x 10-5mol/l in
aqueous solutionfor 100-fold dilution. Ameth-
opterin (Methotrexate, Lederle Laboratories
Div.) and adenosine were used at final
concentration of 10-6 mol/l and 5 x 10-5
mol/l respectively.
Radioisotopes.-Thymidine-6- 3H (Schwarz
Bioresearch Inc., specific activity 15*5
Ci/mmol), thymidine-14C (New England
Nuclear Corp., s.a. 4 mCi/mmol), 1-(3H-4,
5)-leucine (Schwarz, s.a. 58 Ci/mmol),
dl-leucine-1-_4C (New England Nuclear
Corp., s.a. 25-6 mCi/mmol), uridine-5-3H
(Nuclear Chicago, s.a. 5 Ci/mmol) and
cytidine-5-3H (Schwarz, s.a. 2-1 Ci/mmol)
were used in studies of protein, RNA and
DNA synthesis. Scintillation counting was
carried out using Scintisol (Isolabs, Akron,
Ohio, U.S.A.) and Packard Tri-Carb spectro-
meters.
Cell culture and counts.-HeLa S-3 cells
with a doubling time of 24 hours were grown
in suspension and monolayer culture (Mueller
et al., 1962); several other cell lines were
also used (see text). Synchrony was induced
in HeLa cells by exposure to amethopterin
and adenosine (10-6 mol/l and 5 X 10-5
mol/l respectively) for 16 hours. Addition
of 10 ,ug thymidine per 106 cells induced a
synchronous wave of S phase cells (Mueller
et al., 1962). Monolayer cells were removed
with 0-1% trypsin, dispersed into a single
cell suspension by vigorous pipetting and
counted byhaemacytometer. Mitotic indices
were obtained from counts of at least 2000
cells in duplicate cultures after fixing with
methanol: acetic acid (3: 1) and staining
with crystalviolet (Schindler, 1963). Analysis
of mitotic stages was usually made on a
minimum of 200 mitotic cells from duplicate
samples.
Macromolecular assays.-Total DNA,
RNA and protein estimations were made on
duplicate culture samples after 2 washes of
cells in ice-cold isotonic saline, precipitation
with 4% perchloric acid, washes in 80%
ethanol, 100% ethanol and ether, followed by
dissolution ofthe dried residue in 90% formic
acid. For scintillation assays, duplicate
samples of the formate were added to
Scintisol. DNA was measured fluorimetrically
by a modified Kissane and Robbins' (1959)
method, RNA by Ceriotti's (1955) orcinol
method, and protein by a modified Lowry
procedure (Oyama and Eagle, 1956).
RESULTS
Effect of bleomycin A2 on monolayer
cultures of HeLa S-3 cells
Exponentially growing HeLa S-3 cells
in 2 oz (57 ml) pharmacy bottles were
exposed to concentrations of bleomycin
from 0*5 ,tg to 50 ,tg/ml. 5 jtg/ml Bleo-
mycin slowed growth considerably but it
required 10 ,ug/ml or more to arrest
growth completely (Fig. 1).
Daily estimates of DNA, RNA and
protein from duplicate pairs of cultures
are shown in Fig. 2-4. Dose levels of
bleomycin A2 which inhibited cell pro-
liferation within the first day of treatment
did not suppress RNA and protein syn-
thesis although DNA synthesis was
inhibited within the first 24 hours of
treatment. As a result of continued
RNA and protein synthesis in the absence
of cell division, cytoplasmic mass
increased while nuclei remained relatively
small. On the second day bleomycin
treated cells (5 and 10 ,tg/ml) showed a
215-230% increase in protein content
per cell (control = 2-42 x 10-4,g/cell).
No damage was seen over 24 hours in
cells blocked with adequately inhibitory,
but not toxic, levels of bleomycin.
Between 24 and 48 hours nucleoli became
enlarged and well circumscribed (cf.
Ogawa and Onoe, 1969), followed by the
nuclei being broken up into a lobulated
pattern with a relatively amorphous
internal consistency. At lower dose levels
(< 5 ,ug/ml), the preservation of cells was
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FIG. 1. Effect of bleomycin A, on HeLa S-3 cell growth in monolayer culture Q O control,
* * 05 ug/ml, A A 1I0 plg/ml, * * 5 plg/ml, O 10,ug/ml, *
50 pg/ml.
remarkably good 4 days or more after
exposure, indicating a low toxicity of
bleomycin on vital cell functions.
Other cell lines in monolayer cultures
HEp2 (humancarcinoma),ML-2 (mouse
epithelial and Chang liver (human epithe-
lial) cell lines in monolayer cultures were
inhibited by similar dose levels of anti-
biotic to HeLa cells. The response of
Chang liver cells is illustrated in Fig. 5.
Effect of Bleomycin A2 on suspension
cultures of HeLa S-3 cells
A far greater sensitivity to bleomycin
A2 (and phleomycin) was observed in
HeLa cells in suspension culture, the
lowest dose tested in monolayer culture
(0 5 /ig/ml) inhibiting cell proliferation in
suspension cultures within a few hours
(Fig. 6). DNA synthesis ceased within
24 hours of bleomycin exposure even at
the lowest dose (O 5 ,ig/ml). RNA
accumulation occurred to nearly the same
extent as in controls over the first 24 hours
except at extreme concentrations (50 0
pg/ml), which produced a definite depres-
sion. By 48 hours there was reduced
RNA synthesis compared with controls.
Protein synthesis was not noticeably
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FiG. 2. Daily estimates of DNA in duplicate cultures of HeLa monolayers used in Fig. 1.
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FIG. 3.-Daily estimates of RNA in HeLa cell monolayers of Fig. ].
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FIG. 4.-Daily estimates of protein in HeLa cell monolayers of Fig. 1.
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FIG. 5. Growth of monolayers ofChang liver cells in
bleomycin. Each point is the average of Coulter
counter estimates from duplicate cultures.
0 - 0 control, A A I ,ug/ml, x x
5 ,ug/ml, C *l 10 ,g/ml, * * 50 ,g/ml.
affected at dose levels up to 5
- 0 /ig/ml
for at least 24 hours and cell massincreased
considerably. One day after bleomycin
treatment, cell protein mass had increased
by 235% at 0 5,ig/ml and 275% at 1P0
,og/ml (control protein 2 * 30 x 10-4 ,ug/
cell).
Suspension culture medium differs
from monolayer medium in that (i) it
contains Ca++ and Mg++ from the serum
alone and (ii) 0l1% pluronic F-68, a
non-ionic detergent is added to prevent
precipitation of protein. Suspension cul-
tures grown in the presence and absence
of pluronic F-68 were equally sensitive.
Conversely, monolayers treated in the
presence and absence of pluronic F-68
had equal sensitivities, which excludes
involvement of the detergent. When
suspension cultures were grown in the
presence of Ca++ and Mg++ at the concen-
tration used for monolayer cultures,
sensitivity was considerably reduced.
Comparisons of the effects of bleomycin
and phleomycin at concentrations as low
as 0 01 pig/ml were made in media with
and without divalent ions using suspen-
sion cultures. Bleomycin at 0 01 and
1.5
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FIG. 6. Effect ofbleomycin A2 on HeLa S-3 cell growth in suspensioi culture. Symbols as for Fig. l.
The asterisks on Days 2 and 3 in the controls denote supplementation wAith fresh medium to ensure
that all cell requirements were fully available throughout the experiment. Corrections were made
for the volumes of fresh medium added.
0*05 jtg/ml did not suppress cell growth in
culture medium containing divalent ions.
In the absence of divalent ions, phleo-
mycin at 0-01 ,ug/ml and 0-05 /ig/ml
inhibited growth by 10-15o and 30-35o
respectively over 48 hours, and bleomycin
at 0*05 ,ug/ml inhibited growth by
20-25%. In Fig. 7 the pronounced
difference caused by the presence of
divalent ions is shown for bleomycin at
0 1 ,ug/ml in suspension culture. Con-
versely, 0 l jtg/ml bleomycin and phleo-
mycin produced greater inhibition of
monolayer cultures grown in Ca++- and
Mg++-free medium than in controls with
normal monolayer medium.
Other suspension cell lines
Other suspension cultured cell lines
were very sensitive to bleomycin and
phleomycin, similar dose levels being
inhibitory for HEp2 and ML-2 cells
grown under identical conditions to HeLa.
It was ofinterest, however, that a suspen-
sion subelone of the BHK 21/C13 fibro-
blastic cell line (BHK 21/Cl3/DWS-3)
122
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FIG.. 7.---Effect of bleomycin A2 on stuspension HeLa S-3 cells in basal Eagle's medium with and
without dlivalent ions. O (O normal BME control, * 0 normal BME + bleomycin 0 1
,ug/ml, O BME without Ca+-+ and Mg++, A -A BME without Ca++ and Mg++ + bleo-
mycin 0 1 ,ig/ml. M.C.--time of medium change.
required more than 200 times as much
bleomycin (Fig. 8) and 100 times as much
phleomycin to inhibit cell proliferation to
the same extent as HeLa S-3 under
identical conditions.
Effect of bleomycin on macromolecildar
synthesis in HeLa cells
Since bleomycin exerts its effects on
suspension cultures more rapidly than on
monolayer cultures, the former were
employed for studies of the uptake of
radioisotopically labelled thymidine and
leiicine by HeLa cells exposed to bleo-
mycin at 1 and 5 ,ug/ml. To emphasize
any impairment of DNA synthesis, cul-
tures were synchronized before treatment
with amethopterin for 16 hours. When
the block was released with thymidine,
bleomycin and the radioactive precursors
were added. Protein synthesis was un-
affected by either 1 or 5 ,ug/ml bleomycin
over 24 hours (see Table I). DNA syn-
thesis was significantly depressed (20-
350o) by the end of the synchronous S
phase (7-8 hours) with 1 ,ig/ml bleomycin,
and by over 50%0 with 5 ,ug/ml bleomycin
(Table I). The plateau developing after
7 or 8 hours of [3H]-thymidine incorpora-
tion into DNA in bleomycin treated
cultures is evidence of the cells failing to
progress through their cycle. None ofthe
groups exposed to bleomycin showed an
increase in cell number, whereas controls
increased by 1 -8 to 1 *9 fold in 24 hours.
In a similar experiment, therate ofprotein
synthesis was found to be unaltered in
synchronized cultures treated with 1 /ag/ml
bleomycin compared with the controls
given 1 hour pulses of [3H]-leucine at
---~
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FIG. 8.-Growth of BHK 21/C13/DWS-3 cells in suspension culture in the presence of bleomycin A2.
0 O control, * * 0-1 ,pg/ml, FL [ 1-0 pg/ml, * * 5-0 pg/ml.
intervals up to 10 hours after release from
an amethopterin block.
In Table II the rate of RNA synthesis
is shown for synchronized and non-
synchronized HeLa cultures treated with
1 ,tg/ml bleomycin as measured by 30 min
pulses with labelled cytidine and uridine.
No suppression was observed over 24
hours.
Amethopterin blocked cells exposed
to bleomycin (1 gtg/ml) for the last 4 hours
before reversal with thymidine were
capable ofinitiating DNA synthesis to the
same extent as controls. Removal of
bleomycin during the S phase in these
cultures suppressed DNA synthesis to a
similar degree to that in which bleomycin
was left in the medium. A similar effect
was noted by Suzuki et al. (1968). The
results are interpreted as an irreversible
interaction of the antibiotic with DNA
and suggest that non-replicating DNA
interacts with bleomycin to the same
extent as replicating.
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TABLE I. -Niffect of Bleomrycin (1 and 5 yg/ml) on DNA and Protein Synthesis in
kSyncht-onized HeLa S-3 C'ells
Precursor
3H]-Td R
Treatmnenit,
Control
Ble.omycin 1 ,Ig/ml
Bleomycin 5 pg/ml
14C]-leuicine Control
Bleomycini 1 jig/ml
Bleomycin 5 ,ug/ml
Average (i/min x 103 at hours after reversal (% relative to control)
1 hour 2 hours 4 hours 8 hours 24 hours
4:3-6 139-0 373 0 647-0 914-0
39 5 (900/) 342-0 (92%) 421-0 (655%) 421-0 (46%)
34-0 (77%o) 108-0 (78%) 214-0 (57%) 281-0 (43%)
3-8
3.4 (89(%)
3-6 (940)
6-6 12-8 24-5 66-2
-- 15-1 (118%) 19-4 (80%) 54-4 (82%)
8-8 (1350o) 13-4 (105%) 22-1 (900o) 60-4 (91%)
Amethopterin-synchronized HeLa S-3 cultures were reversed with thymidine which included
) 1 Iuc/ml thymidine-6-3H, and also supplied with l-leucine-1- 4C at 0 05 ,lic/ml. Bleomycin or saline was
d(1(led at this time. At, intervals thereafter the accumulated radioactivity incorporated in the acid insoluble
'ractions was estimate(d by simultaneous 3H an(d 14C counting.
TABLE II. Incorporation of RNA Precursors into Synchronized HeLa S-3 Cells in
the Presence of Bleomnycin (1 ,ig/ml)
Precursor
'ynjchron ized cultures
[-3H]-cytidline
[3H1]-tiri(line
Von-snchronized cultures
[3H]-cytidine
Treatmenit
Bleomycin I I,g/ml
Bleomycin 1 /,tg/ml
Bleomycin 1 ,ug/ml
Relative percentage of control incorporation of
radioisot,ope after reversal with thymidine (hours)
0-5-1-0 1-5-2-0 3-5-4 0 7-5-8-0 23-5-24-0
112 95 98 103
70 92 112 103
123
95 102 121 127 100
Details of experimental design as given in Table I except that these cultures received 30 min pulses of
~ri Iat( ui ine? or c,yti(lille
Tolonyforming ability of cells after
,xposure to bleomycin
Suspension cultured HeLa S-3 cells in
Dxponential growth phase were exposed
For periods of up to 24 hours to 1 pg/ml
bleomycin A2. Samples were removed at
regular intervals, diluted to 100 cells/ml,
nd 5 ml dispersed into 60 mm petri
lishes containing bleomycin-free condi-
tioned monolayer culture medium. The
-lishes were incubated at 37°C for 8 days.
,olonies were counted after 400 neutral
buffered formaldehyde fixation and
rnethylene blue staining. Cell viability
was not completely lost but within about
2 hours only about 500 survived and at
I hours viability was negligible (Fig. 9).
Whether this represents a short phase of
resistance as found with phleomycin
'Djordjevic and Kim, 1967) is not known.
Wthen cells were plated out in the
same manner as described above from
untreated HeLa S-3 suspension cultures
into petri dishes containing media with
1 ,tg/ml bleomycin, some cells persisted
for up to one week. Continued incubation
of the dishes for 1 month did not result in
the appearance of bleomycin resistant
colonies. Similarly, colonies never formed
in dishes returned to bleomycin free
medium for 3-4 weeks after exposure to
1 ,tg/ml bleomycin for 1 or 2 days.
Time of action of bleornycin during the
cell cycle
Since bleomycin and phleomycin both
have significant inhibitory effects on DNA
synthesis, they will inhibit cells from
entering mitosis which have not com-
pleted replication of the genome, i.e. the
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FIG. 9.-Clonability of HeLa S-3 suspension cultured cells exposed to 1 ug/mI bleomycin. * 0 Colonies counted onlyif at least 32 cells (5 divisions) innumber, 0- - -* colonies of 8 cells or more.
cells will not enter G2. However, the
following experiments demonstrate that
(i) bleomycin is a highly effective anti-
mitotic agent in the G2 phase, (ii) mitotic
cells themselves are not blocked by the
antibiotic and (iii) bleomycin can inhibit
entry of cells into mitosis at levels which
have no quantitatively detectable effect
on DNA synthesis.
Synchronized HeLa cells were allowed
to synthesize DNA for 8 hours after
release from an amethopterin block, i.e.
apprpximately the duration of S phase.
Colcemid was then added with or
without bleomycin. A control given 2
mmol/l hydroxyurea and colcemid was
also included. The percentages of
arrested metaphases were counted 6 hours
later. Addition ofhydroxyureaprecluded
the possibility of cells still in S phase at
the time of treatment from reaching
mitosis. The G2 population, which is
unaffected by hydroxyurea, progressed
into mitosis and was arrested by colcemid
(Wheatley, 1972). At 6 hours (i.e. 14
hours afterthymidinereversal) metaphases
had reached 26% in the hydroxyurea/ colcemid control and 62% in the free-
running colcemid control. In contrast,
culturesgivenbleomycin showed a marked
inhibition of the accumulation of meta-
phases which was considerably greater than that caused by the hydroxyurea block, only 9% cells having reached
mitosis. It was deduced that 1 ,ag/ml
bleomycin in suspension cultured HeLa
cells exerts its maximal anti-mitotic
effect in 25-30 min, G2 being 2*5-2*8
hours in duration in this experiment. In
similar experiments, the addition of
bleomycin or phleomycin together with
hydroxyurea to cultures gave identical
results to the addition of antibiotic
alone. The speed of action of bleomycin is borne out by prophase counts in syn- chronously growing HeLa cell cultures
falling to less than 10% of control values
between 30 and 60 min after treatment
with bleomycin at 1 ,g/ml (Fig. lOa). In
this experiment colcemid was also added
and the inhibition of metaphase accumu-
lation is clearly shown (Fig. lOb).
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Unsynchronized HeLa cell cultures
were treated with bleomycin and hydroxy-
urea to avoid the possibility that the
synchronization itself affected the sensi-
tivity of cells to the antibiotic. Bleo-
mycin at 0 5, 1 0 and IO,tg/ml was
added to logarithmically growing HeLa
cell suspensions with 2 mmol/l hydroxy-
urea. Untreated controls maintained a
mitotic index ofabout 4% (Fig. 11). The
index in cultures treated with 2 mmol/l
hydroxyureafelltoabouthalfin 3hoursand
was very low from 4 hours onwards. The
area under this curve represents the flow
of G2 cells into mitosis (Wheatley, 1972).
Bleomycin treatments shifted the curve
closer to the ordinate showing that a
large part of the G2 cohort had been
prevented from progressing into mitosis.
Allowing time for cells already in mitosis
to move into interphase (30-60 min),
the delay before a completely inhibitory
127
IftIft128 D. N. WHEATLEY, G. C. MUELLER AND K. KAJIWARA
5
4
U C.)
0
E
ICC,
3
2
1
0
'C
0. 2 4 6 8
Hours after treatment
FIG. 11.-Effect of bleomycin on the progression of suspension cultured HeLa S-3 cells ilito mitosis in asynchronous cultures. x x cdntrol, A A 2 mmol/l hydroxyurea, A A 1 ,yg/ml bleomycin, * * 5 ,ug/ml, 0 -- 10 ,lg/ml.
TABLE III.-Effect of Bleomycin (10-100 igq/nld) on Prophases in HeLa S-3
Suspension Cultures
Bleomycin yig/ml
Control
10 ,g/ml
20 ,ug/ml
50 ,ug/ml
100 ,ug/ml
Percentage prophases at time after treatment (min)
10 20 30 45 60 90
0-26 0-28 0-35 0 30 0-30 0-26
0-12 0-15 0-10 0-12 0-00 0-02
0-02 0-00 0-07 0-05 0-12 0-07
0-00 0-00 0-00 0-00 0-00 0-00
0-05 0-00 0-00 0-00 0-00 0-00
Prophases were counted in duplicate cultures for each time point, not less than 2000 cells being included in each individual count.
TABLE IV. DNA Synthe,sis in Synchronized HeLa S-3 Cultures Treated with
Phleomycin and Bleomycin (0 1 ag/ml) and the Ability of Cells to Reach
MJitosis
Treatment
Control
Bleomycin 0-1 ,ug/ml
Phleomycin 0-1 ,g/ml
[3H]-Thymidine incorpoiation ct/min x 103/,ug piotein
(percentage of control) at stated hours after reversal
2 hours 4 hours 7 hours 13 5 hours
58 - 4 (100) 133 - 0 (100) 173 - 2 (100) 213 - 0 (100)
60-7 (104) 128-8 (97) 176-3 (102) 227-0 (107)
63-0 (108) 128-6 (97) 180-8 (104) 222-0 (105)
Relative increase in
cell number as
percentage of
control at 13-5 hours
100
66
56
Thymidine-6-3H (0- 1 Ci/mi, 4 mCi/mmol) incorporation measurecd in duplicate suspension cultures of HeLa S-3 cells after reversal from amethopterin block.BLEOMYCIN INHIBITION OF HELA CELLS
action of 10 ,tg/ml bleomycin was observed
must be considerably less than 30 min.
Using high dose levels of bleomycin
(10-100 ,ug/ml) an inhibitory effect on
progression of cells into prophase was seen
within minutes of treatment (Table III).
Bleomycin has no inhibitory effect on the
progression of mitotic cells through divi-
sion at dose levels well above those
required to arrest entry into mitosis
(5-10 /,g/ml) (Fig. 12). Finally, it was
1.0
x
la
0
E
0.5
0 1 2 3 4 5
HOURS
Fic.. 12. Mitotic HeLa cells collecte(d by
mechanical dislodigement were immediately
exposed (O hour) to blcomycin 5 pg/ml
,( O O) or me(lium without the anti-
biotic (- 0).
demonstrated that very low dose levels of
bleomycin and phleomycin can signifi-
cantly suppress division in suspension
cultured HeLa cells without quantitatively
affecting the amount of DNA synthesis
within the cells (Table IV).
DISCUSSION
While the effects of bleomycin on the
growth kinetics of HeLa cells in mono-
layer culture reported here are generally in
agreement with the findings of others
(Ichikawa et al., 1967; Kunimoto et al.,
1967; Suzuki et al., 1968; Tanaka et al.,
1963b), the most important difference is
the demonstration of a far greater sensi-
tivity in suspension culture, which also
applies to phleomycin. This has been
largely attributable to the absence
of divalent ions. Permeability of cells
to the antibiotics could be con-
siderably affected by the presence of Ca++
and Mg++ although Pietsch et al. (1969)
maintain that phleomycin is freely diffus-
ible across biological membranes. This
possibility is being investigated for bleo-
mycin. Sensitivity was also found to
vary with cell type, in general epithelial
cells being more susceptible than fibro-
blasts. Indeed, HeLa cells in suspension
culture are two orders of magnitude more
sensitive than the suspension adapted
sub-strain of the BHK 21/C13 cell line
(DWS-3) grown under identical conditions.
This contrasts with the report ofTerasima
and Umezawa (1970) that mouse L-strain
fibroblasts of the L5 sub-strain are
considerably more sensitive than HeLa
cells. However, comparisons of results
from different laboratories where different
cells, culture methods and batch prepara-
tions of antibiotic have been used, are
unlikely to be particularly reliable. In
the present study, an attempt has been
made to standardize the culture medium
before testing with the same preparation
of antibiotic; differences in sensitivity
are probably due to inherent properties
of the cells themselves.
The ability of a particular cell type to
concentrate bleomycin once it has gained
access to the cell may also play a part in
differential sensitivity. There is some
evidence from in vivo studies that epithe-
lial cells (e.g. the basal layer of the
epidermis) concentrate [3H]-bleomycin
(Umezawa et al., 1968a). Another possi-
bility is that certain cells might inactivate
bleomycin by releasing proteolytic
enzymes just as in vitro treatment of
bleomycin with pronase can inactivate it
(Haidle, 1971). In this laboratory we
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have passed medium containing bleomycin
at critical inhibitory concentrations from
one culture to another over 5-6 days
without detecting loss ofinhibitory action.
An alternative is that cell sensitivity is
inversely related to antibiotic activation
within the cell (Muller et al., 1972).
Sensitivity differences could be related
to the access of bleomycin to the DNA,
its degree of binding and the amount of
excision damage it can produce. These
points are dealt with elsewhere (Muller et
al., 1972) and the possibility need only be
raised here of Ca++ or Mg++ affecting the
interaction of bleomycin with the target
molecules rather than some earlier
sequence in the chain of events. The
value of bleomycin in chemotherapy lies
chiefly in its selectivity of action on
certain tissue elements. The underlying
causes of the differences in sensitivity
discussed here warrant further investi-
gation since they may help to elucidate
the mechanism of action and to improve
the design of selective chemotherapeutic
agents.
Bleomycin and phleomycin have a
particularly powerful inhibitory action
on post-S phase (G2) cells. Their action
on suspension cultured HeLa cells is very
rapid even at low concentrations.
Virtually no delay in disappearance of
prophases was seen with high dose levels
of bleomycin (Table III) which suggests
that there is no completely resistant phase
at the end of G2. The antibiotics both
act over the entire G2 period, which
agrees with the finding of Djordjevic and
Kim (1967). In plant cells, bleomycin
and phleomycin are also effective inhibi-
tors throughout G2 (Hotta and Stern,
1969).
The suppression of DNA synthesis
by the antibiotics potentiates their anti-
mitotic activity. We have found that
very low concentrations of bleomycin
(0.1 ,ug/ml or less) exert some antimitotic
action on HeLa S-3 suspension cells in
the absence of quantitatively detectable
suppression of DNA synthesis, suggesting
that G2 events are considerably more
sensitive than DNA replication. The
interference of the antibiotics with DNA
replication is becoming clearer from recent
studies (Suzuki et al., 1969, 1970; Tera-
sima, Yasukawa and Umezawa, 1970;
Haidle, 1971; Muller et al., 1972). It has
been shown that bleomycin causes strand
scission of DNA, but, unlike irradiation-
induced mitotic delay, it is suspected that
damage cannot be as easily repaired and
cells are permanently held in G2. The
cleavage of DNA molecules by bleomycin
must occur in the post-replication phase
if the mechanism of inhibiting cell entry
into mitosis is radiomimetic in nature.
We are presently attempting to correlate
the degree of strand scission with the
sensitivity of different cell lines, and the
same cell lines under different conditions,
to bleomycin.
It is of particular interest that tran-
scriptional processes are quantitatively
unaffected by the interaction of the anti-
biotics with DNA until long after mitotic
activity has ceased and DNA replication
suppressed. Little is known of the site
of interaction between bleomycin and
DNA although the site of interaction of
phleomycin with DNA is different from
that of actinomycin D which does inter-
fere with transcription (Pietsch, 1969).
The use of the antibiotics in cell cycle
analyses to collect and hold cells in G2
without quantitatively altering transcrip-
tional and translational processes should
make it possible to comparegeneticexpres-
sion in G2 with that at other stages of the
cycle. Studies of this nature are in
progress (Wheatley, in preparation).
Qualitative and quantitative differences
in proteins synthesized by G2 cells com-
pared with cells at other stages of the cell
cycle may exist (Kolodny and Gross,
1969). It is hoped that bleomycin and
phleomycin will help to elucidate the
significance of the G2 phase of the cell
cycle and the trigger mechanism for
mitosis. Their effectiveness at low con-
centrations in HeLa S-3 cells, the irrever-
sibility of their action and the lack of
early interference with RNA and protein
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synthesis suggest that a very specific
intracellular target is involved.
Much of this was carried out during
tenure of a Medical Research Council
Travelling Fellowship at the McArdle
Laboratory for Cancer Research, Univer-
sity of Wisconsin, Madison, Wisconsin
53706, U.S.A. (DNW). It was also sup-
ported by the Cancer Research Campaign.
Technical assistance was provided by Mrs
Sandra Remmer and Mrs Marget Inglis.
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